Home Cart 0 Sign in  
X

[ CAS No. 56-95-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 56-95-1
Chemical Structure| 56-95-1
Chemical Structure| 56-95-1
Structure of 56-95-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 56-95-1 ]

Related Doc. of [ 56-95-1 ]

Alternatived Products of [ 56-95-1 ]

Product Details of [ 56-95-1 ]

CAS No. :56-95-1 MDL No. :MFCD00012532
Formula : C26H38Cl2N10O4 Boiling Point : -
Linear Structure Formula :- InChI Key :WDRFFJWBUDTUCA-UHFFFAOYSA-N
M.W : 625.55 Pubchem ID :9562059
Synonyms :
Hibitane diacetate
Chemical Name :1,1'-Hexamethylenebis[5-(p-chlorophenyl)biguanide] diacetate

Safety of [ 56-95-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 56-95-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 56-95-1 ]

[ 56-95-1 ] Synthesis Path-Downstream   1~21

  • 2
  • [ 56-95-1 ]
  • chlorhexidine dihydrate [ No CAS ]
YieldReaction ConditionsOperation in experiment
With potassium hydroxide; In water; at 50℃;pH 11.0;Product distribution / selectivity; Chlorhexidine (C22H30N10Cl2), obtained commercially, was reacted with sodium hydroxide to form chlorhexidine dihydrate (C22H30N10Cl2.1.3H2O). Approximately 100 g of a starting material <strong>[56-95-1]chlorhexidine diacetate</strong> was dissolved in 1300 mL of warm deionized water at approximately 50 C. 6 M potassium hydroxide (KOH) was added drop-wise with stirring. A precipitate formed immediately and continued to form upon addition of base until the solution reached a pH of 11. The precipitate was filtered and washed six times with warm, 50 C., deionized water, and then dried in an oven at 60 C. to produce approximately 78 g of chlorhexidine dihydrate. These compounds were analyzed using energy dispersive x-ray spectroscopy (EDX), Fourier transform infrared spectroscopy (FTIR), thermogravimetric analysis (TGA), and proton nuclear magnetic resonance (1H NMR),EDXChlorhexidine and chlorhexidine dihydrate were analyzed using EDX, a technique well known to those of skill in the art. Table 1 provides both the theoretical and actual elemental composition of chlorhexidine and chlorhexidine dihydrate obtained from the EDX analysis.; FTIRFTIR was used to compare the characteristic peaks of different functional groups in chlorhexidine dihydrate and chlorhexidine. Chlorhexidine had peaks at 3513, 3473, 3410, 3371 cm-1, characteristic of N-H stretching, and peaks at 1635 and 1595 cm-1, characteristic of aromatic and aliphatic guanidine absorptions (ArNHC(N-H)NHAr) and ((CH3)2NC(N-H)C(CH3)2). The chlorhexidine dihydrate spectrum of FIG. 3 had peaks at 3458 and 3406 cm-1, characteristic of N-H stretching. The decreased frequencies likely were attributable to hydrogen bonding. The chlorhexidine dihydrate spectrum also had a broad band between 3300-2850 cm-1 that was characteristic of an intermolecular OH hydrogen-bonded bridge (typically appearing between 3405 and 2936 cm-1). Chlorhexidine dihydrate also had the aromatic guanadine peak at 1605 cm-1. The decreased frequency, again, likely was attributable to hydrogen bonding.TGATGA was used to determine the moisture content of chlorhexidine base (FIG. 4) and chlorhexidine dehydrate (FIG. 5). As shown by the derivative weight loss curve of FIG. 5, there was a loss of a small molecule (presumably water) at 100 C. and a mass decrease of 4.700% at 120.07 C. for chlorhexidine dihydrate. The mass loss likely corresponded to the 3.98% water present in the chlorhexidine dihydrate.1H NMRProton nuclear magnetic resonance (1H NMR) spectroscopy was used to analyze the structure of chlorhexidine dihydrate. The 1H NMR spectrum of chlorhexidine (FIG. 6) had peaks at 8.5, 7.25, 7.0, 3.3, 3.15, 1.9, 1.6, 1.4, and 1.25 ppm. The 1H NMR spectrum of chlorhexidine dihydrate (FIG. 7) had peaks at 8.5, 7.2, 6.9, 3.3, 3.15, 1.85, 1.6, 1.35, and 1.25 ppm, similar to that of chlorhexidine. The intensities, however, were different. Specifically, the peak at 8.5 ppm was significantly less intense in the chlorhexidine dihydrate spectrum. The peaks at 8.5, 1.85, and 1.35 ppm showed no spin-spin coupling and were therefore in rapid equilibrium in the deuterated methanol solvent (tautomerization). The water appeared to preferentially stabilize some of the tautomers of chlorhexidine.
  • 3
  • [ 56-95-1 ]
  • [ 55-56-1 ]
YieldReaction ConditionsOperation in experiment
With potassium hydroxide; In water; at 50℃;pH 11.0; Commercially obtained chlorhexidine (C22H30N10Cl2), obtained commercially, was reacted with sodium hydroxide to form chlorhexidine hydrate. Approximately 100 g of a starting material <strong>[56-95-1]chlorhexidine diacetate</strong> was dissolved in 1300 ml of warm deionized water at approximately 50 C. 6 M potassium hydroxide (KOH) was added drop-wise with stirring. A precipitate formed immediately and continued to form upon addition of base until the solution reached a pH of 11. The precipitate was filtered and washed six times with warm, 50 C., deionized water, and then dried in an oven at 60 C. to produce approximately 78 g of chlorhexidine hydrate.The chlorhexidine hydrate has a theoretical formulation of C22H30N10Cl2.nH2O. In multiple production runs, the chlorhexidine hydrate product was determined to have an actual degree of hydration (n) of about 1.4.
  • 4
  • copper(II) choride dihydrate [ No CAS ]
  • [ 64-17-5 ]
  • [ 56-95-1 ]
  • C22H30Cl6Cu2N10*2C2H6O [ No CAS ]
  • 5
  • [ 64-17-5 ]
  • [ 56-95-1 ]
  • [ 7789-45-9 ]
  • C22H30Br4Cl2Cu2N10*2C2H6O [ No CAS ]
  • 6
  • [ 64-17-5 ]
  • [ 6046-93-1 ]
  • [ 56-95-1 ]
  • C22H30Cl2CuN10(2+)*2C2H3O2(1-)*C2H6O [ No CAS ]
  • 7
  • [ 64-17-5 ]
  • [ 6046-93-1 ]
  • [ 56-95-1 ]
  • C26H36Cl2Cu2N10O4(2+)*2C2H3O2(1-)*2C2H6O [ No CAS ]
  • 8
  • copper(II) choride dihydrate [ No CAS ]
  • [ 56-95-1 ]
  • C22H30Cl4CuN10*2H2O [ No CAS ]
  • 9
  • [ 56-95-1 ]
  • [ 7789-45-9 ]
  • C22H30Br2Cl2CuN10*1.5H2O [ No CAS ]
  • 10
  • [ 56-95-1 ]
  • [ 4800-94-6 ]
  • chlorhexidine carbenicillin [ No CAS ]
YieldReaction ConditionsOperation in experiment
93% In water; butan-1-ol; at 20.0℃; for 48.0h; General procedure: The synthesis and physical characterization of four beta-lactam-based chlorhexidine GUMBOS, namely chlorhexidine di-ampicillin, chlorhexidine carbenicillin, chlorhexidine di-cephalothin and chlorhexidinedi-oxacillin, were performed using methods previously reported by Cole et al. (2013) [24], but with slight modification. Briefly, stoichiometric amounts of <strong>[56-95-1]chlorhexidine diacetate</strong> and beta-lactam antibiotic, with the latter in slight excess, was stirred for 48 h at room temperature in a butanol:water (1:1) mixture to ensure the complete formation of the beta-lactam-based chlorhexidine GUMBOS. After removing butanol from the GUMBOS products, they were purified by washing several times with cold deionized water and dried overnight with a high vacuum. The structures of chlorhexidine di-ampicillin, chlorhexidine carbenicillin, chlorhexidine di-oxacillin and chlorhexidine di-cephalothin (Figure 1) were mainly confirmed by NMR, mass spectrometry and elemental analysis, among other spectroscopic data.
  • 11
  • [ 56-95-1 ]
  • [ 58-71-9 ]
  • chlorhexidine dicephalothin [ No CAS ]
YieldReaction ConditionsOperation in experiment
83% In water; butan-1-ol; at 20℃; for 48.0h; General procedure: The synthesis and physical characterization of four beta-lactam-based chlorhexidine GUMBOS, namely chlorhexidine di-ampicillin, chlorhexidine carbenicillin, chlorhexidine di-cephalothin and chlorhexidinedi-oxacillin, were performed using methods previously reported by Cole et al. (2013) [24], but with slight modification. Briefly, stoichiometric amounts of <strong>[56-95-1]chlorhexidine diacetate</strong> and beta-lactam antibiotic, with the latter in slight excess, was stirred for 48 h at room temperature in a butanol:water (1:1) mixture to ensure the complete formation of the beta-lactam-based chlorhexidine GUMBOS. After removing butanol from the GUMBOS products, they were purified by washing several times with cold deionized water and dried overnight with a high vacuum. The structures of chlorhexidine di-ampicillin, chlorhexidine carbenicillin, chlorhexidine di-oxacillin and chlorhexidine di-cephalothin (Figure 1) were mainly confirmed by NMR, mass spectrometry and elemental analysis, among other spectroscopic data.
  • 12
  • [ 56-95-1 ]
  • [ 1173-88-2 ]
  • chlorhexidine dioxacillin [ No CAS ]
YieldReaction ConditionsOperation in experiment
85% In water; butan-1-ol; at 20℃; for 48.0h; General procedure: The synthesis and physical characterization of four beta-lactam-based chlorhexidine GUMBOS, namely chlorhexidine di-ampicillin, chlorhexidine carbenicillin, chlorhexidine di-cephalothin and chlorhexidinedi-oxacillin, were performed using methods previously reported by Cole et al. (2013) [24], but with slight modification. Briefly, stoichiometric amounts of <strong>[56-95-1]chlorhexidine diacetate</strong> and beta-lactam antibiotic, with the latter in slight excess, was stirred for 48 h at room temperature in a butanol:water (1:1) mixture to ensure the complete formation of the beta-lactam-based chlorhexidine GUMBOS. After removing butanol from the GUMBOS products, they were purified by washing several times with cold deionized water and dried overnight with a high vacuum. The structures of chlorhexidine di-ampicillin, chlorhexidine carbenicillin, chlorhexidine di-oxacillin and chlorhexidine di-cephalothin (Figure 1) were mainly confirmed by NMR, mass spectrometry and elemental analysis, among other spectroscopic data.
  • 13
  • [ 56-95-1 ]
  • [ 69-52-3 ]
  • chlorhexidine diampicillin [ No CAS ]
YieldReaction ConditionsOperation in experiment
98% In water; butan-1-ol; at 20℃; for 48.0h; General procedure: The synthesis and physical characterization of four beta-lactam-based chlorhexidine GUMBOS, namely chlorhexidine di-ampicillin, chlorhexidine carbenicillin, chlorhexidine di-cephalothin and chlorhexidinedi-oxacillin, were performed using methods previously reported by Cole et al. (2013) [24], but with slight modification. Briefly, stoichiometric amounts of <strong>[56-95-1]chlorhexidine diacetate</strong> and beta-lactam antibiotic, with the latter in slight excess, was stirred for 48 h at room temperature in a butanol:water (1:1) mixture to ensure the complete formation of the beta-lactam-based chlorhexidine GUMBOS. After removing butanol from the GUMBOS products, they were purified by washing several times with cold deionized water and dried overnight with a high vacuum. The structures of chlorhexidine di-ampicillin, chlorhexidine carbenicillin, chlorhexidine di-oxacillin and chlorhexidine di-cephalothin (Figure 1) were mainly confirmed by NMR, mass spectrometry and elemental analysis, among other spectroscopic data. Chlorhexidine di-ampicillin. Off-White Solid, yield 98%, Water solubility: 126 mug/mL. Solubilityproduct constant (Ksp): 4.63 × 10-12 M3. 1H-NMR (400 Hz, DMSO-d6) delta 8.58-8.36 (m, 2 H) 7.21-7.50(m, 18 H), 5.08 (d, J = 2.74 Hz, 2 H), 4.96 (s, 4 H), 3.69 (d, J = 3.13 Hz, 2 H), 3.26 (s, 2 H), 3.07 (dt,J = 7.04, 6.65 Hz, 4 H), 1.85 (s, 4 H), 1.57 (s, 6 H), 1.49 (s, 4 H), 1.46 (quin, 4 H), 1.44 (s, 4 H), 1.27(quin, 4 H), 1.17 (s, 6 H), 1.15 (s, 2 H). 13C-NMR (101 MHz, DMSO) delta 180.88, 72.88, 172.36, 166.94,166.76, 139.07, 128.24, 127.01-128.43, 121.90, 76.07, 68.38, 60.80, 60.01, 58.64, 27.38, 26.76, 25.97.Anal. calcd. for C54H68Cl2N16O8S2: C, 53.86; H, 5.69; Cl, 5.89; N, 18.61; O, 10.63; S, 5.33. Found: C,53.22; H, 5.81; Cl, 5.56; N, 18.37; S, 5.16. HRMS (ESI) m/z calcd. for C54H68Cl2N16O8S2, [M+H+],1203.4424; found, 1203.4136.
  • 14
  • nickel(II) chloride hexahydrate [ No CAS ]
  • [ 56-95-1 ]
  • [Ni(chlorhexidine)]Cl2*2H2O [ No CAS ]
YieldReaction ConditionsOperation in experiment
In ethanol; for 2.0h;Heating; General procedure: The nickel(II) complexes, chlorhexidinenickel(II) chloride dihydrate (complex 1), chlorhexidinenickel(II) bromide dihydrate (complex 2) and chlorhexidinenickel(II) acetate ethanolate(complex 3), were prepared by the following general method. <strong>[56-95-1]Chlorhexidine diacetate</strong>monohydrate, 0.6435 g (1 mmol), was dissolved in 30 mL ethanol, under slight heating. Therequired solid metal salt, i.e., NiCl2·6H2O (0.2377 g, 1.0 mmol for complex 1), NiBr2·(0.2185g, 1.0 mmol for complex 2) and Ni(CH3COO)2·4H2O (0.2486 g, 1.0 mmol for complex 3),was added slowly under stirring, keeping the temperature below 40 C. The color of thesolutions became orange after a few minutes. The precipitate began to form after 2 h of stirringwith heating. The mixture was left overnight and then the orange precipitate was filteredoff, washed with ethanol and dried under air.
  • 15
  • [ 56-95-1 ]
  • nickel dibromide [ No CAS ]
  • [Ni(chlorhexidine)]Br2*2H2O [ No CAS ]
YieldReaction ConditionsOperation in experiment
In ethanol; for 2.0h;Heating; General procedure: The nickel(II) complexes, chlorhexidinenickel(II) chloride dihydrate (complex 1), chlorhexidinenickel(II) bromide dihydrate (complex 2) and chlorhexidinenickel(II) acetate ethanolate(complex 3), were prepared by the following general method. <strong>[56-95-1]Chlorhexidine diacetate</strong>monohydrate, 0.6435 g (1 mmol), was dissolved in 30 mL ethanol, under slight heating. Therequired solid metal salt, i.e., NiCl2·6H2O (0.2377 g, 1.0 mmol for complex 1), NiBr2·(0.2185g, 1.0 mmol for complex 2) and Ni(CH3COO)2·4H2O (0.2486 g, 1.0 mmol for complex 3),was added slowly under stirring, keeping the temperature below 40 C. The color of thesolutions became orange after a few minutes. The precipitate began to form after 2 h of stirringwith heating. The mixture was left overnight and then the orange precipitate was filteredoff, washed with ethanol and dried under air.
  • 16
  • [ 64-17-5 ]
  • [ 6018-89-9 ]
  • [ 56-95-1 ]
  • [Ni(chlorhexidine)](CH3COO)2*C2H5OH [ No CAS ]
YieldReaction ConditionsOperation in experiment
for 2.0h;Heating; General procedure: The nickel(II) complexes, chlorhexidinenickel(II) chloride dihydrate (complex 1), chlorhexidinenickel(II) bromide dihydrate (complex 2) and chlorhexidinenickel(II) acetate ethanolate(complex 3), were prepared by the following general method. <strong>[56-95-1]Chlorhexidine diacetate</strong>monohydrate, 0.6435 g (1 mmol), was dissolved in 30 mL ethanol, under slight heating. Therequired solid metal salt, i.e., NiCl2·6H2O (0.2377 g, 1.0 mmol for complex 1), NiBr2·(0.2185g, 1.0 mmol for complex 2) and Ni(CH3COO)2·4H2O (0.2486 g, 1.0 mmol for complex 3),was added slowly under stirring, keeping the temperature below 40 C. The color of thesolutions became orange after a few minutes. The precipitate began to form after 2 h of stirringwith heating. The mixture was left overnight and then the orange precipitate was filteredoff, washed with ethanol and dried under air.
  • 17
  • [ 56-95-1 ]
  • palladium dichloride [ No CAS ]
  • chlorhexidinepalladium(II) tetrachloridopalladate(II) dihydrate [ No CAS ]
YieldReaction ConditionsOperation in experiment
In ethanol; acetonitrile; at 20℃; for 2.0h; General procedure: The palladium(II) complexes, chlorhexidinepalladium(II) tetrachloridopalladate(II) dihydrate(complex 4) and chlorhexidinepalladium(II) acetate (complex 5), were obtained by mixinga solution of PdCl2 dissolved in acetonitrile with a solution of chlorhexidine dissolved inethanol, using a 2:1 metal:ligand mole ratio for complex 4 and a 1:1 mole ratio for complex 5.Complex 4 was prepared by adding an ethanolic solution of <strong>[56-95-1]chlorhexidine diacetate</strong> monohydrate(0.6435 g, 1.0 mmol, in 30 mL ethanol) to a refluxing solution containing 0.3546 g(2.0 mmol) of PdCl2 dissolved in acetonitrile. The resulting suspension that was immediatelyformed was stirred at room temperature for 2 h and then filtered under vacuum. The orangeprecipitate was washed with ethanol and dried under air. Complex 5, orange, was obtained inthe same way as complex 4, but using a 1:1 metal:ligand mole ratio, by mixing 0.6435 g (1.0mmol) of ligand dissolved in 30 mL ethanol and 0.1773 g (1.0 mmol) of PdCl2 in acetonitrile.
  • 18
  • [ 56-95-1 ]
  • palladium dichloride [ No CAS ]
  • [Pd(chlorhexidine)](CH3COO)2 [ No CAS ]
YieldReaction ConditionsOperation in experiment
In ethanol; acetonitrile; at 20℃; for 2.0h; General procedure: The palladium(II) complexes, chlorhexidinepalladium(II) tetrachloridopalladate(II) dihydrate(complex 4) and chlorhexidinepalladium(II) acetate (complex 5), were obtained by mixinga solution of PdCl2 dissolved in acetonitrile with a solution of chlorhexidine dissolved inethanol, using a 2:1 metal:ligand mole ratio for complex 4 and a 1:1 mole ratio for complex 5.Complex 4 was prepared by adding an ethanolic solution of <strong>[56-95-1]chlorhexidine diacetate</strong> monohydrate(0.6435 g, 1.0 mmol, in 30 mL ethanol) to a refluxing solution containing 0.3546 g(2.0 mmol) of PdCl2 dissolved in acetonitrile. The resulting suspension that was immediatelyformed was stirred at room temperature for 2 h and then filtered under vacuum. The orangeprecipitate was washed with ethanol and dried under air. Complex 5, orange, was obtained inthe same way as complex 4, but using a 1:1 metal:ligand mole ratio, by mixing 0.6435 g (1.0mmol) of ligand dissolved in 30 mL ethanol and 0.1773 g (1.0 mmol) of PdCl2 in acetonitrile.
  • 19
  • chromium(III) chloride hexahydrate [ No CAS ]
  • [ 56-95-1 ]
  • dichloridochlorhexidinechromium(III) acetate [ No CAS ]
YieldReaction ConditionsOperation in experiment
In ethanol; at 40 - 50℃; for 1.0h; General procedure: The chromium(III) complex, dichloridochlorhexidinechromium(III) acetate (complex 6)was prepared by adding a solution of CrCl36H2O (0.266 g, 1.0 mmol) in ethanol to a solutionof chlorhexidine ligand in ethanol (0.6435 g, 1.0 mmol) and the reaction mixture was heatedat 40-50 C, under constant stirring, for 1 h. The light blue precipitate obtained was separatedby filtration under vacuum, washed with ethanol and dried under air.
  • 20
  • [ CAS Unavailable ]
  • [ CAS Unavailable ]
  • [ 56-95-1 ]
  • [ 93107-08-5 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
Stage #1: hydrogenchloride; bismuth(III) citrate; chlorhexidine diacetate; ciprofloxacin hydrochloride at 40℃; for 0.25h; Stage #2: With ammonium hydroxide at 20℃; for 12h; 3.2. Preparation of the CIP-Bi-CHX Composite The ciprooxacin-bismuth-chlorhexidine (CIP-Bi-CHX) composite was synthesizedaccording to the patent procedure no 235823 [48] by dissolving bismuth(III) salt in dilutehydrochloric acid, then mixing with chlorhexidine and ciprofloxacin in the ratio1:1:1. The substances were added sequentially: first-CIP, later-CHX (method 1) orfirst-CHX, later-CIP (method 2). The syntheses were carried out with stirring at 40 Cfor 15 min. Next the reaction medium was basified to precipitation with dilute ammoniumhydroxide and allowed to stand at room temperature for 12 h. The pale yellowishprecipitate was filtered, washed with water-ethanol (1:1 v/v) solution and dried in a desiccatorunder vacuum. Bi(CIP)(CHX)2Cl, molecular formula: C39H47BiCl4FN13O3, formulaweight: 1115.67 g/moL, composition: C(41.99%) H(4.25%) Bi(18.73%) Cl(12.71%) F(1.70%)N(16.32%) O(4.30%).
  • 21
  • [ CAS Unavailable ]
  • [ 56-95-1 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
In water at 20℃; for 2h; 1 Synthesis of Ceftriaxone-based GUMBOS: General procedure: Ceftriaxone-based GUMBOS were synthesized by use of ion-exchange reactions in deionized water. This reaction scheme is illustrated in Fig. 1. Briefly, stoichiometrically equivalent amounts of disodium ceftriaxone and antiseptic, chlorhexidine diacetate (CHX 2Ac) and octenidine dihydrochloride (OCT 2HCI), were mixed for two hours at room temperature. The resulting products were washed several times with cold, deionized water and lyophilized overnight. The resulting ceftriaxone-based GUMBOS, chlorhexidine-ceftriaxone ([CHX][CRO]) and octenidine-ceftriaxone ([OCT][CRO])
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 56-95-1 ]

Aryls

Chemical Structure| 2113-05-5

[ 2113-05-5 ]

1-(3-Chlorophenyl)biguanide hydrochloride

Similarity: 0.80

Chemical Structure| 55-57-2

[ 55-57-2 ]

N-Phenylimidodicarbonimidic diamide hydrochloride

Similarity: 0.66

Chemical Structure| 14018-90-7

[ 14018-90-7 ]

1-Phenylguanidine xcarbonate

Similarity: 0.64

Chemical Structure| 140-38-5

[ 140-38-5 ]

1-(4-Chlorophenyl)urea

Similarity: 0.63

Chemical Structure| 1187933-29-4

[ 1187933-29-4 ]

1-(4-Chlorophenyl)azetidine-3-carboxylic acid

Similarity: 0.61

Chlorides

Chemical Structure| 2113-05-5

[ 2113-05-5 ]

1-(3-Chlorophenyl)biguanide hydrochloride

Similarity: 0.80

Chemical Structure| 140-38-5

[ 140-38-5 ]

1-(4-Chlorophenyl)urea

Similarity: 0.63

Chemical Structure| 1187933-29-4

[ 1187933-29-4 ]

1-(4-Chlorophenyl)azetidine-3-carboxylic acid

Similarity: 0.61

Chemical Structure| 99497-03-7

[ 99497-03-7 ]

Domperidone xmaleate

Similarity: 0.60

Chemical Structure| 2327-02-8

[ 2327-02-8 ]

1-(3,4-Dichlorophenyl)urea

Similarity: 0.60

Amines

Chemical Structure| 2113-05-5

[ 2113-05-5 ]

1-(3-Chlorophenyl)biguanide hydrochloride

Similarity: 0.80

Chemical Structure| 55-57-2

[ 55-57-2 ]

N-Phenylimidodicarbonimidic diamide hydrochloride

Similarity: 0.66

Chemical Structure| 14018-90-7

[ 14018-90-7 ]

1-Phenylguanidine xcarbonate

Similarity: 0.64

Chemical Structure| 140-38-5

[ 140-38-5 ]

1-(4-Chlorophenyl)urea

Similarity: 0.63

Chemical Structure| 2327-02-8

[ 2327-02-8 ]

1-(3,4-Dichlorophenyl)urea

Similarity: 0.60

Related Parent Nucleus of
[ 56-95-1 ]

Guanidines

Chemical Structure| 2113-05-5

[ 2113-05-5 ]

1-(3-Chlorophenyl)biguanide hydrochloride

Similarity: 0.80

Chemical Structure| 55-57-2

[ 55-57-2 ]

N-Phenylimidodicarbonimidic diamide hydrochloride

Similarity: 0.66

Chemical Structure| 14018-90-7

[ 14018-90-7 ]

1-Phenylguanidine xcarbonate

Similarity: 0.64

Chemical Structure| 93982-96-8

[ 93982-96-8 ]

N,N-Diphenylguanidine Monohydrobromide

Similarity: 0.59

Chemical Structure| 1142945-81-0

[ 1142945-81-0 ]

1-(4-(2-(Pyrrolidin-1-yl)ethoxy)phenyl)guanidine 2,2,2-trifluoroacetate

Similarity: 0.53